• DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia/India
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

How to build a health commons approach to pandemic preparedness and response

16 January 2023, 2-4 PM Geneva

Geneva, Switzerland and online

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

Hybrid event, co-hosted by DNDi, UCL Institute for Innovation and Public Purpose, & Friends of the Independent Panel

Participation in-person at DNDi office in Geneva or online

In its May 2021 report, the Independent Panel for Pandemic Preparedness and Response (IPPPR) recommended a commons approach to research and development for pandemic tools, and several other groups have explored strategies for the effective sharing of knowledge and technologies for public health purpose.

The aim of this workshop is to start to identify the key elements of a collective framework to organize, finance, and coordinate health innovation by public and private sectors. It will discuss some of the latest economic thinking on collective ownership, explore current examples of managing collective knowledge to develop vaccines and treatments for PPR and help identify areas where policy makers can and should act to increase our collective capabilities for the development and equitable delivery of health technologies for pandemic preparedness and response.

The outcome of these discussions will inform policy discussions towards a new framework for pandemic tools, including a meeting entitled “Advancing a new approach to pandemic tools as common goods”, convened by the former Independent Panel co-chair Rt Hon Helen Clark at the Rockefeller Bellagio Centre on 14-16 February 2023.

Diagnostics, vaccines and therapeutics are critical to global pandemic preparedness and response (PPR), and ensuring equitable access to both the underlying knowledge technologies and products requires managing them other than as privately owned commodities.

Building a policy framework to foster more equitable system from R&D to access thus implies a form of collective investment, with shared ownership and clearly defined access rules developed collaboratively around a shared purpose, for instance public health or outbreak and pandemic control. While there has been much discussion around global public goods there has been less focus on how the evolving concepts of “the commons” and “common good approaches” could offer a promising policy framework around which to develop a more sustainable and equitable approach to PPR.

A critical aspect for outbreak response is the ability to rapidly generate effective diagnostics, treatments, and vaccines, and roll them out at the required scale where needed. One way for achieving rapid innovation is through adapting existing technology platforms to new health challenges, in particular for vaccines, or repurposing existing treatments.  Freedom to use knowledge and access to the technical knowhow with technology transfer as needed will be critical to increase our collective capacity to respond to outbreaks anywhere. Enabling such collective capacity could be achieved through a common good approach.

Clinical trials for new drugs or vaccines for PPR must happen as part of the epidemic control response. It is therefore important to establish, in advance, independent and public health-focused trial capacity to swiftly evaluate different interventions in a standardized, comparable, and transparent manner. A commons-based approach that stipulates user and access rights and responsibilities around clinical trial data generated through pre-established clinical trial platforms can enable conditioning access to the platform for developers, including private companies, to binding commitments about the further development, registration, availability, and access.

A collective approach requires the deliberate creation of appropriate legal, policy and institutional frameworks for collective ownership and governance outside the commercial realm, promoting access and user rights rather than exclusive ownership.

Watch recording

Agenda

Moderator: Spring Gombe, Partner and Principal, Public Affairs Practice, Market Access Africa

Introduction and framing

Rt Hon Helen Clark, former co-chair of The Independent Panel

Keynote – Health for All: From a public good to a common good approach

Professor Mariana Mazzucato, Founder and Director, Institute for Innovation and Public Purpose (IIPP), University College London, and Chair of the WHO Council on the Economics of Health for All

“Health for All: moving from market fixing public goods to market shaping around the common good”

Initiatives to deliver common goods for health

Technology sharing and managing collective knowledge within the WHO mRNA technology transfer Hub
Chan Park, General Counsel, Medicines Patent Pool
Knowledge sharing within the Moonshot consortium
Annette Von Delft, Translational Scientist, Centre for Medicines Discovery, University of Oxford
Using emerging technologies for improving NTDs diagnostics: Open Science principles applied to AI and local manufacturing for medical labs in Africa
Thomas Hervé Mboa Nkoudou, Researcher at CEIMIA and Founder of the Mboa Lab

Respondents:

  • Suerie Moon, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, and DNDi Board Member
  • Benjamin Coriat, En Communs, Université Paris Sorbonne
  • Sangeeta Shashikant, Legal Advisor, Coordinator Development and Intellectual Property Programme, Third World Network
  • Viviana Munoz Tellez, Coordinator, Health, Intellectual Property and Biodiversity Programme (HIPB), South Centre

Discussion

Closing remarks

  • Els Torreele, Friends of the Independent Panel and Institute for Innovation and Public Purpose
  • Luis Pizarro, Executive Director, DNDi

Other events

Loading...
6 February 2023, 5 PM Madrid

Madrid, Spain and online

La Salud Global y las Enfermedades Tropicales Desatendidas en su día mundial

30 January 2023, 5-8 PM Hamburg

Hamburg, Germany

World NTD Day 2023: Snack & Talk about NTDs

29 January 2023

Referral Hospital, Baniapur, Saran, Bihar

Honouring frontline heroes of NTDs

26 January 2023

Santa Cruz de Tenerife, Spain

Jornada enfermedades tropicales desatendidas, cooperación en salud y farmacia solidaria

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo